Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Comphya logo — Providing a better solution for non-responders to oral drugs...

Comphya

Providing a better solution for non-responders to oral drugs.

Founded 2017 Switzerland Ecublens, Switzerland 8 employees Convertible Note Total: $5.28M Biotechnology, Health Care +1

General Information

Company Name Comphya
Founded Year 2017
Location Switzerland Ecublens, Switzerland +1
Employees 8
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Convertible Note
Social

Get notified when Comphya moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Comphya

Comphya is an innovative medical device startup founded in 2017, specializing in the development of the CaverSTIM device. The company's flagship product, CaverSTIM, utilizes cutting-edge neuroprosthetics expertise to restore erectile function in patients who do not respond to oral drugs. This groundbreaking technology involves implanting a neuro-stimulator in the pelvic cavity to selectively activate the nerve responsible for triggering penile erection. CaverSTIM comprises an implantable pulse generator (IPG), connected to an electrode paddle, external controllers for patients and physicians, and a wireless recharger. The company has garnered significant attention, receiving a Fr.850.00KConvertible Note investment on 31 January 2023 from Praxis Spinal Cord Institute. Comphya operates in the Biotechnology and Health Care industries and holds great potential in addressing an unmet medical need for patients struggling with erectile dysfunction.

Taxonomy: Neuroprosthetics, Erectile Dysfunction Treatment, Neuro-stimulator, Implantable Pulse Generator, Healthcare Innovation, Medical Technology, Neuroscience, Healthcare Devices, Innovative Healthcare Solutions

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 1
Investor
31 Jan 2023
Convertible Note •••••• 1 •••• •••• 01 Dec 2020
Seed Round •••••• 3
Investor Investor
•••• •••• 		26 Jun 2019
Debt Financing •••••• 1 •••• •••• 30 Nov 2017
Grant •••••• 1
Investor
05 Sep 2017

View All 6 Funding Rounds

Latest News

View All
Dutch Men’s health startup Fellos lands €2 million to tackle sensitive issues like ED and PE through... — Eu-startups
Dutch Men’s health startup Fellos lands €2 million to tackle sensitive issues like ED and PE through telehealth
Eu-startups Oct 07, 2025

Comphya Alternatives & Competitors

Comphya vs
Liris Tech
Liris Tech Switzerland

LIRIS is a complete Swiss management software solution for your ophthalmological practice

10 employees
Health Care, Information Technology
Comphya vs
Swiss Medical Group
Swiss Medical Group Argentina

Conectate con lo que te hace bien

7461 employees
Comphya vs
PRISTEM
PRISTEM Switzerland

Global Diagnostics

Unknown
17 employees
Health Care

FAQ About Comphya

Providing a better solution for non-responders to oral drugs.
Comphya was founded in 2017.
Comphya is headquartered in Ecublens, Switzerland.
Comphya operates in the following industries: Biotechnology, Health Care, Life Sciences.
Comphya has approximately 8 employees.
Comphya has completed 6 funding rounds, raising a total of $5.28M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Comphya include Liris Tech, Swiss Medical Group, PRISTEM, Swiss Healthcare Startups, SUMEX AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Comphya and Liris Tech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Comphya and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy